{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T04:54:36Z","timestamp":1781499276088,"version":"3.54.1"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cutaneous squamous cell carcinoma (cSCC) carries a risk of postoperative local recurrence, with nearly 90% of events occurring within 3 years; however, prognostic tools tailored to Asian populations remain limited. This study aimed to identify independent risk factors for postoperative local recurrence and develop a nomogram to predict individualized 1-, 2-, and 3-year recurrence probabilities in patients with cSCC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Clinicopathological data from 603 patients with cSCC who underwent surgical treatment alone at four Chinese centers were retrospectively analyzed. Patients were randomly divided into a training cohort and a validation cohort at a ratio of 7:3. Univariable and multivariable Cox proportional hazards regression analyses were performed in the training cohort to identify independent predictors of postoperative local recurrence. A nomogram was then constructed based on these independent risk factors. The prognostic performance of the model was evaluated using time-dependent receiver operating characteristic curves, calibration curves, and decision curve analysis. Finally, the total nomogram score was calculated for each patient, and all patients were categorized into low-, intermediate-, and high-risk groups based on the optimal cutoff values. Kaplan\u2013Meier analysis was then performed to compare recurrence-free survival among the different risk groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 603 patients were included, with 422 in the training cohort and 181 in the validation cohort. During follow-up, 77 recurrence events were observed. Multivariable Cox regression identified age, tumor size, tumor thickness, histologic differentiation, regional stage, and AJCC stage as independent predictors of recurrence. These predictors were incorporated into a nomogram for individualized recurrence risk estimation. The model demonstrated good discrimination, with area under the curve values ranging from 0.759 to 0.869, along with strong calibration and favorable clinical utility in decision curve analysis. Based on the total nomogram score, patients were stratified into low-risk (&amp;lt;99.0), intermediate-risk (99.0\u2013143.9), and high-risk (\u2265144.0) groups, with significant differences in recurrence-free survival among the three groups (log-rank p &amp;lt; 0.0001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      This nomogram provides a practical tool for individualized prognostic assessment and may support individualized clinical decision-making for 1-, 2-, and 3-year outcomes\n                      <jats:sup>1<\/jats:sup>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1876978","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T04:25:35Z","timestamp":1781497535000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic model for three-year postoperative local recurrence in cutaneous squamous cell carcinoma: a Chinese multicenter cohort study"],"prefix":"10.3389","volume":"16","author":[{"given":"Yuanhong","family":"Liu","sequence":"first","affiliation":[{"name":"Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzheng","family":"Zheng","sequence":"additional","affiliation":[{"name":"Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Song","sequence":"additional","affiliation":[{"name":"Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuebao","family":"Shao","sequence":"additional","affiliation":[{"name":"Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Chen","sequence":"additional","affiliation":[{"name":"Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbo","family":"Bu","sequence":"additional","affiliation":[{"name":"Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guomin","family":"Li","sequence":"additional","affiliation":[{"name":"Dermatology Hospital, Southern Medical University","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixiong","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Affiliated Hospital of Nantong University","place":["Nantong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihao","family":"Chen","sequence":"additional","affiliation":[{"name":"Faculty of Engineering, The University of Sydney","place":["Sydney, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Fang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Affiliated Hospital of Nantong University","place":["Nantong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruzeng","family":"Xue","sequence":"additional","affiliation":[{"name":"Dermatology Hospital, Southern Medical University","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifang","family":"Zhai","sequence":"additional","affiliation":[{"name":"Department of Dermatology, the First Affiliated Hospital, Army Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqun","family":"Jiang","sequence":"additional","affiliation":[{"name":"Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16101800","article-title":"Cutaneous squamous cell carcinoma: an updated review","volume":"16","author":"Jiang","year":"2024","journal-title":"Cancers"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2023.108226","article-title":"Global, regional and national burdens of non-melanoma skin cancer attributable to occupational exposure to solar ultraviolet radiation for 183 countries, 2000-2019: a systematic analysis from the WHO\/ILO joint estimates of the work-related burden of disease and injury","volume":"181","author":"Pega","year":"2023","journal-title":"Environ Int"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.7150\/jca.20496","article-title":"Vulvar cancer in China: epidemiological features and risk analysis","volume":"8","author":"Xiao","year":"2017","journal-title":"J Cancer"},{"key":"B4","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1186\/s12967-025-06470-x","article-title":"Human papilloma virus (HPV) mediated cancers: an insightful update","volume":"23","author":"Baba","year":"2025","journal-title":"J Transl Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2019.2996","article-title":"Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study","volume":"5","author":"Fitzmaurice","year":"2019","journal-title":"JAMA Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(08)70178-5","article-title":"Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study","volume":"9","author":"Brantsch","year":"2008","journal-title":"Lancet Oncol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1001\/jamadermatol.2013.2139","article-title":"Factors predictive of recurrence and death from cutaneous squamous cell carcinoma: a 10-year, single-institution cohort study","volume":"149","author":"Schmults","year":"2013","journal-title":"JAMA Dermatol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1001\/jamadermatol.2013.3339","article-title":"Rerecurrence 5 years after treatment of recurrent cutaneous basal cell and squamous cell carcinoma","volume":"149","author":"Hamilton","year":"2013","journal-title":"JAMA Dermatol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jaad.2022.03.044","article-title":"Adjuvant radiation following clear margin resection of high T-stage cutaneous squamous cell carcinoma halves the risk of local and locoregional recurrence: a dual-center retrospective study","volume":"87","author":"Ruiz","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1001\/jamadermatol.2019.0032","article-title":"Performance of the american joint committee on cancer staging manual, 8th edition vs the brigham and women\u2019s hospital tumor classification system for cutaneous squamous cell carcinoma","volume":"155","author":"Ruiz","year":"2019","journal-title":"JAMA Dermatol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2023.113251","article-title":"European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: diagnostics and prevention-update 2023","volume":"193","author":"Stratigos","year":"2023","journal-title":"Eur J Cancer"},{"key":"B12","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jaad.2018.06.060","article-title":"Comparing the eighth and the seventh editions of the American Joint Committee on Cancer staging system and the Brigham and Women\u2019s Hospital alternative staging system for cutaneous squamous cell carcinoma: implications for clinical practice","volume":"80","author":"Ca\u00f1ueto","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.10.007","article-title":"Guidelines of care for the management of cutaneous squamous cell carcinoma","volume":"78","author":"Kim","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.48.5326","article-title":"Evaluation of american joint committee on cancer, international union against cancer, and brigham and women\u2019s hospital tumor staging for cutaneous squamous cell carcinoma","volume":"32","author":"Karia","year":"2014","journal-title":"J Clin Oncol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2024.06.072","article-title":"Most cutaneous squamous cell carcinoma recurrences occur in the first 3 years after diagnosis: a multicenter retrospective cohort study","volume":"91","author":"Granger","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3479","article-title":"Recurrent and metastatic cutaneous squamous cell carcinomas in a cohort of 774 patients in Finland","volume":"100","author":"Korhonen","year":"2020","journal-title":"Acta Derm Venerol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2008.08073.x","article-title":"Can nomograms be superior to other prediction tools","volume":"103","author":"Shariat","year":"2009","journal-title":"BJU Int"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)71116-7","article-title":"Nomograms in oncology: more than meets the eye","volume":"16","author":"Balachandran","year":"2015","journal-title":"Lancet Oncol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/S0090-4295(02)02395-6","article-title":"National comprehensive cancer network guidelines for the management of prostate cancer","volume":"61","author":"Scherr","year":"2003","journal-title":"Urology"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.2260","article-title":"Nomograms for predicting long-term overall survival and cancer-specific survival in lip squamous cell carcinoma: a population-based study","volume":"8","author":"Hu","year":"2019","journal-title":"Cancer Med"},{"key":"B21","unstructured":"Summary staging manual - 2018"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6947-8-53","article-title":"Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers","volume":"8","author":"Vickers","year":"2008","journal-title":"BMC Med Inform Decis Mak"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2024.11.082","article-title":"Prevalence of poor outcomes in cutaneous squamous cell carcinoma by AJCC and BWH tumor stages: a systematic review and meta-analysis","volume":"92","author":"Zakhem","year":"2025","journal-title":"J Am Acad Dermatol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.17188","article-title":"Recurrence rates of cutaneous squamous cell carcinoma of the head and neck after Mohs micrographic surgery vs. standard excision: a retrospective cohort study","volume":"181","author":"van Lee","year":"2019","journal-title":"Br J Dermatol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1001\/jamadermatol.2015.4994","article-title":"Risk factors for cutaneous squamous cell carcinoma recurrence, metastasis, and disease-specific death: a systematic review and meta-analysis","volume":"152","author":"Thompson","year":"2016","journal-title":"JAMA Dermatol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1001\/jamadermatol.2013.2456","article-title":"Evaluation of AJCC tumor staging for cutaneous squamous cell carcinoma and a proposed alternative tumor staging system","volume":"149","author":"Jambusaria-Pahlajani","year":"2013","journal-title":"JAMA Dermatol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1001\/jamadermatol.2025.0128","article-title":"Risk factor number and recurrence, metastasis, and disease-related death in cutaneous squamous cell carcinoma","volume":"161","author":"Ran","year":"2025","journal-title":"JAMA Dermatol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21389","article-title":"Head and neck cancers\u2014major changes in the American joint committee on cancer eighth edition cancer staging manual","volume":"67","author":"Lydiatt","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1097\/DSS.0000000000003085","article-title":"Sentinel lymph node biopsy in high-risk cutaneous squamous cell carcinoma: analysis of a large size retrospective series","volume":"47","author":"Tremblay-Abel","year":"2021","journal-title":"Dermatol Surg"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2022.5508","article-title":"Association of patient risk factors, tumor characteristics, and treatment modality with poor outcomes in primary cutaneous squamous cell carcinoma: a systematic review and meta-analysis","volume":"159","author":"Zakhem","year":"2023","journal-title":"JAMA Dermatol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-1501","article-title":"Clinical and histological prognostic factors for local recurrence and metastasis of cutaneous squamous cell carcinoma: analysis of a defined population","volume":"93","author":"Roozeboom","year":"2013","journal-title":"Acta Derm Venereol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1097\/SAP.0000000000000110","article-title":"The effect of differentiation grade of cutaneous squamous cell carcinoma on excision margins, local recurrence, metastasis, and patient survival: a retrospective follow-up study","volume":"75","author":"Brinkman","year":"2015","journal-title":"Ann Plast Surg"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.08.059","article-title":"Cutaneous squamous cell carcinoma: incidence, risk factors, diagnosis, and staging","volume":"78","author":"Que","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.11.046","article-title":"Identifying Brigham and Women\u2019s Hospital stage T2a cutaneous squamous cell carcinomas at risk of poor outcomes","volume":"86","author":"Gupta","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-024-03184-w","article-title":"Grading differentiation in cutaneous squamous cell carcinoma: a review of the literature","volume":"316","author":"Diede","year":"2024","journal-title":"Arch Dermatol Res"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2022.12.057","article-title":"Dermatopathologic features of cutaneous squamous cell carcinoma and actinic keratosis: consensus criteria and proposed reporting guidelines","volume":"88","author":"Christensen","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1080\/03610730802545051","article-title":"Change in frailty and risk of death in older persons","volume":"35","author":"Buchman","year":"2009","journal-title":"Exp Aging Res"},{"key":"B38","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1186\/s12874-023-02109-x","article-title":"Competing-risks analysis for evaluating the prognosis of patients with microinvasive cutaneous squamous cell carcinoma based on the SEER database","volume":"23","author":"Zheng","year":"2023","journal-title":"BMC Med Res Methodol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2010.02767.x","article-title":"Competing risk of death: an important consideration in studies of older adults","volume":"58","author":"Berry","year":"2010","journal-title":"J Am Geriatrics Soc"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.17551","article-title":"Age over 90\u2009years is an unfavorable prognostic factor for resectable cutaneous squamous cell carcinoma","volume":"52","author":"Saito-Sasaki","year":"2024","journal-title":"J Dermatol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.2340\/actadv.v101.347","article-title":"Age-related differences in tumour characteristics and prognostic factors for disease progression in cutaneous squamous cell carcinoma of the head and neck","volume":"102","author":"Leus","year":"2021","journal-title":"Acta Derm Venereol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.rec.2011.03.016","article-title":"An introduction to competing risks analysis","volume":"64","author":"Pintilie","year":"2011","journal-title":"Rev Espa\u00f1ola Cardiolog\u00eda (English Edition)"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu131","article-title":"Competing risks analyses: objectives and approaches","volume":"35","author":"Wolbers","year":"2014","journal-title":"Eur Heart J"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33109","article-title":"Differences in site\u2010specific incidence and relative survival of cutaneous and mucocutaneous genital squamous cell carcinoma in Germany, 2007\u20102015","volume":"147","author":"Stang","year":"2020","journal-title":"Intl J Cancer"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijwd.2020.05.008","article-title":"Sex-based differences in the anatomic distribution of cutaneous squamous cell carcinoma","volume":"6","author":"Kim","year":"2020","journal-title":"Int J Women\u2019s Dermatol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2012.09.030","article-title":"Fitzpatrick skin phototype is an independent predictor of squamous cell carcinoma risk after solid organ transplantation","volume":"68","author":"Gogia","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2014.154","article-title":"NOTCH1 mutations occur early during cutaneous squamous cell carcinogenesis","volume":"134","author":"South","year":"2014","journal-title":"J Invest Dermatol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30459","article-title":"Differential mutation frequencies in metastatic cutaneous squamous cell carcinomas versus primary tumors","volume":"123","author":"Yilmaz","year":"2017","journal-title":"Cancer"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9072228","article-title":"Deciphering the molecular landscape of cutaneous squamous cell carcinoma for better diagnosis and treatment","volume":"9","author":"Lazar","year":"2020","journal-title":"JCM"},{"key":"B50","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1186\/s12967-025-06957-7","article-title":"Identification of prognostic liquid biopsy biomarkers in patients with cutaneous squamous cell carcinoma treated with cemiplimab","volume":"23","author":"Vanni","year":"2025","journal-title":"J Transl Med"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1876978\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T04:25:41Z","timestamp":1781497541000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1876978\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":50,"alternative-id":["10.3389\/fonc.2026.1876978"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1876978","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]},"article-number":"1876978"}}